Looks like you’re on the UK site. Choose another location to see content specific to your location

Fujifilm Sells Medical Business Unit to Astorg
Fujifilm Irvine Scientific has strategically decided to sell its Medical Business Unit (MBU) to Astorg. This decision highlights a realignment within Fujifilm, focusing its resources on life sciences while providing Astorg the opportunity to nurture the MBU. The integration is underway, targeting a seamless transition by January 2026.
The MBU at Fujifilm Irvine Scientific has been primarily engaged in producing key products for the medical media market. Recognising the diverse growth paths of its divisions, Fujifilm opted to divest the MBU to better concentrate on its core life sciences operations. This move is crucial as it allows Fujifilm Irvine Scientific to further establish itself as a reliable supplier in the life sciences sector, while the MBU is expected to benefit from Astorg’s expertise and investment, thereby thriving under new ownership.
This transaction points to strategic realignments within companies as they seek to capitalise on their strengths in specific areas. By tapping into Astorg’s resources and market acumen, the MBU aims to expand its market reach and innovation capability, potentially impacting job opportunities and sector growth positively.
The sale of the MBU to Astorg signifies Fujifilm’s sharpened focus on life sciences, setting the stage for both companies to flourish in their respective fields. With the transition slated for completion by early 2026, both Fujifilm Irvine Scientific and Astorg are poised to leverage this change for future growth and advancements.
For the latest updates and in-depth insights into the world of Life Science, including breakthrough treatments, industry trends, and regulatory news, contact James Higgins today!
We have hundreds of jobs available across the Healthcare industry, find your perfect one now.
Stay informed
Receive the latest industry news, Tips
and straight to your inbox.
- Share Article
- Share on Twitter
- Share on Facebook
- Share on LinkedIn
- Copy link Copied to clipboard